Superworth

Nanoviricides EPS NNVC

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.40
Latest quarter, Q4 FY26
−$0.10
Fiscal year 2026
−$0.40

Nanoviricides' earnings per share was −$0.40 over the twelve months to Jun 30, 2026.

In its latest quarter, Q4 FY26, it was −$0.10.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2026−$0.40n/a
FY2025−$0.64n/a
FY2024−$0.70n/a
FY2023−$0.75n/a
FY2022−$0.71n/a
FY2021−$0.81n/a
FY2020−$2.38n/a
FY2019−$2.34n/a
FY2018−$2.40n/a
FY2017−$3.40n/a
FY2016−$3.80n/a
FY2015−$1.30n/a
FY2014−$6.40n/a
FY2013−$4.00n/a
FY2012−$2.94n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q4 FY26−$0.10n/a−$0.40
Q3 FY26−$0.09n/a−$0.43
Q2 FY26−$0.11n/a−$0.48
Q1 FY26−$0.10n/a−$0.51
Q4 FY25−$0.13n/a−$0.64
Q3 FY25−$0.14n/a−$0.70
Q2 FY25−$0.14n/a−$0.72
Q1 FY25−$0.23n/a−$0.76
Q4 FY24−$0.19n/a−$0.70
Q3 FY24−$0.16n/a−$0.82
Q2 FY24−$0.18n/a−$0.81
Q1 FY24−$0.17n/a−$0.78

Against its peers

Companies in Drug Manufacturers - General nearest Nanoviricides' size, closest first, today.

CompanyEPS, 12 monthsGrowth
NNVCNanoviricides−$0.40
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Nanoviricides

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.